Abstract The review lists the genetic diseases reported in Lebanese individuals, surveys genetic programs and services, and highlights the absence of basic genetic health services at the individual and community level. The incidence of individual diseases is not determined, yet the variety of genetic diseases reported is tremendous, most of which follow autosomal recessive inheritance reflecting the social norms in the population, including high rates of consanguinity, which favor the increase in incidence of these diseases. Genetic services including all activities for the diagnosis, care, and prevention of genetic diseases at community level are extremely inadequate. Services are limited to some clinical and laboratory diagnostic services with no genetic counseling. These services are localized within the capital thus preventing their accessibility to high-risk communities. Screening programs, which are at the core of public health prevention services, are minimal and not nationally mandated. The absence of adequate genetic services is attributed to many factors undermining the importance of genetic diseases and their burden on society, the most important of which is genetic illiteracy at all levels of the population, including high-risk families, the general public, and most importantly health care providers and public health officials. Thus, a country like Lebanon, where genetic diseases are expected to be highly prevalent, is in utmost need for community genetics services. Strategies need to be developed to familiarize public health officials and medical professionals with medical genetics leading to a public health infrastructure that delivers community genetics services for the prevention and care of genetic disorders at community level.
Introduction
Lebanon is a small country on the Mediterranean Sea, occupying no more than 10,500 km 2 (4,015 mi 2 ). The Lebanese population residing in Lebanon is estimated at about 4 million people (WHO). However, this population consists of a wide range of ethnicities and religions because of the many occupations and major immigration events into the country since about 47,000 years ago until the beginning of the twentieth century (Zalloua et al. 2008b ). The rich history of the country led to the existence of about 17 officially recognized ethnoreligious communities, harboring a large array of pathogenic and polymorphic gene variations. In addition, throughout modern history, millions of Lebanese immigrants formed multiple Diaspora around the world. The Lebanese Diaspora led to the spread of genetic diseases to geographically distant locations, most of which are reported in the scientific literature of research-advanced countries.
The historic and social structure of the Lebanese population residing in Lebanon or elsewhere favors the high prevalence of a variety of rare and common genetic diseases. Perhaps, the most strongly associated reason would be the deeply rooted sociological norm of consanguinity, defined as a marriage among blood relatives, in addition to endogamous and arranged marriages within a community. Consanguinity rates in Lebanon, as estimated through a cross-sectional study, are still considered relatively high in comparison to developed countries, averaging around 35.5 % (Barbour and Salameh 2009) . To assess the public health impact of genetic diseases reported in Lebanese individuals and to better understand the need for community genetics services including public health programs for screening and prevention, we performed a comprehensive literature search of the Catalogue of Transmission Genetics in Arabs (CTGA) database, Online Mendelian Inheritance in Man (OMIM) database, and PubMed articles, reviews, and book chapters written on genetic diseases in Lebanon and the region. Below, we present a list of any encountered heritable or inherited genetic disease reported in Lebanese residing in Lebanon or in the Lebanese Diaspora.
The last time such a review was attempted was in 1980, at a time when Lebanon had planned to follow the trend in developing countries to deliver care, attention, and prevention for diseases causing chronic disablement such as genetic diseases (Der Kaloustian et al. 1980) . The aim of the review is to provide physicians and researchers with a comprehensive list of reported genetic diseases in patients of Lebanese origin. In addition, the report aims at highlighting the need for community genetics services and public health genetics programs in Lebanon which are essential in decreasing the incidence and reducing the severity of congenital disorders and genetic diseases at the population level through the introduction of proper diagnosis, screening, and counseling. Community genetics is the art and science of utilizing health-and diseaserelated genetics knowledge to benefit individuals in human populations and communities. The goal of community genetics is the prevention and control of genetic diseases at population level through appropriate public health measures and programs and, at the same time, the delivery of genetics services (diagnosis and counseling) in the community for individuals and families. Thus, the term "community genetics services" is used interchangeably with community genetics (Ten Kate et al. 2010) 
Spectrum of genetic diseases in the Lebanese
Currently, the CTGA represents a continuously updated catalogue of gene variants and heritable genetic diseases in Arab individuals. Starting at only 374 observations in 2004, the database now contains over 900 entries, showing major improvements in reporting discovered diseases. However, it was brought to our attention, by officials running the CTGA, that the data from Lebanon is not yet fully surveyed or compiled. CTGA lists 157 diseases reported in Lebanese; an OMIM search adds another 58 diseases, bringing the total to 215 diseases diagnosed in Lebanese individuals. Our PubMed search for articles, reviews, and book chapters yielded an additional 163 diseases not reported in any of the two major human genetic disease databases, all of which were identified in at least one Lebanese patient from Lebanon or the Lebanese Diaspora. Table 1 lists all 378 diseases, along with their OMIM numbers and the most recent publications linking these diseases to Lebanese patients. The list of chromosomal abnormalities encountered is large due to the unpredictability of the mechanism by which these abnormalities arise. Table 1 lists the three chromosomal abnormalities reported in Lebanon and described in OMIM. Other common chromosomal abnormalities reported in Lebanon include trisomy 13 and trisomy 18, in addition to a number of sex chromosome abnormalities such as Turner syndrome and Klinefelter syndrome, among others (Mahfouz et al. 2001) .
Classification according to mode of inheritance and affected systems
It is not surprising to conclude from the data that around 67 % of the reported genetic diseases follow autosomal recessive inheritance, a pattern similar to what is observed in the rest of the Arab world (Al-Gazali et al. 2006 ). This observation is most likely explained by the Arab region having among the highest rates of consanguinity in the world (Tadmouri et al. 2009 ). Several studies highlight the contribution of consanguinity in Lebanon to the high rate of autosomal recessive diseases, such as β-thalassemia (Inati et al. 2006) , Familial Mediterranean fever (Mansour et al. 2001) , phenylalanine hydroxylase deficiency (Karam et al. 2013a) , and a broad category of aminoacidopathies and organic acidemias (Karam et al. 2013b) . Out of all the reported cases of the abovementioned autosomal recessive diseases, 63, 33, 43, and 60 % of cases, respectively, were found to be due to consanguinity. Autosomal dominant disorders are less common representing 17 % of all reported genetic diseases, followed by X-linked diseases being the least common at around 6 % ( Fig. 1) .
According to WHO-International Classification of Disease (WHO-ICD10), congenital malformations and chromosomal abnormalities are the most common around 32 % of all reported diseases. Endocrine, nutritional, and metabolic disorders represent about 29 %, which compared to other Arab countries shows an increase most likely due to two major centers in Lebanon focused on identifying biochemical disorder causing an over reporting of this category.
Incidence of genetic diseases in the Lebanese
Genetic diseases in Lebanon, like other Arab countries, are frequent with an incidence among the highest in the world (Tadmouri et al. 2009 ). Several factors contribute to this high incidence (Hamamy and Alwan 1994; Lindner et al. 2007 ). These include the limited availability of genetic services and public health programs aimed at the prevention and care of genetic diseases; the high rates of consanguinity, which specifically increase the incidence of recessive diseases, and the common large family sizes which increase their occurrence within one family; the high frequency of advanced maternal age, increasing the predisposition to chromosomal trisomies; and advanced paternal age, increasing the risk of autosomal dominant disorders through the occurrence of new mutations. Information on the individual incidence rates is not readily available for all the listed diseases. However, the groups of diseases commonly identified and determined by CTGA database to be of relatively high incidence are shown in Table 1 . It is also noteworthy to mention that around 30 diseases in the literature are only reported in the Lebanese population and not in any of the other Arab countries. Moreover, a few other diseases are strictly confined to patients of Lebanese origin and have not even been reported in any other genome around the world. These diseases have been given OMIM numbers and are reported either in OMIM or the CTGA database (Table 1) .
Genetic services
Comprehensive genetic services, capable of delivering proper diagnosis, care, and prevention of genetic diseases at the community level, must include the following: (i) clinical and laboratory diagnostic services provided by clinical geneticists (physicians who specialize in genetic disorders), nurse geneticists (RN with genetics training), and laboratory geneticists (PhDs or MDs who are trained and certified to perform and interpret genetic tests in one or more of the three clinical genetics laboratory specialties-Clinical Molecular Genetics, Clinical Cytogenetics, or Clinical Biochemical Genetics; (ii) genetic counseling, ideally delivered by trained genetic counselors; and (iii) prevention programs including premarital and carrier screening, prenatal screening and newborn screening (NBS), and prenatal and preimplantation genetic diagnosis (PGD) (Christianson and Modell 2004; health, W. s. d. o. 2008; Modell 1997; Organization 2010) . Despite the above reported numbers of congenital and genetically determined disorders and the high incidence of recessive disease directly linked to the increased rate of consanguinity, genetic services vary greatly in nature and location leading to their selectivity, inadequacy, and insufficiency to cover high-risk communities. Most of the available services are focused on clinical and laboratory diagnosis. Although those services available insure high standard genetic diagnosis in the rapidly expanding world of genetic technology, community genetic services focusing on early detection, prevention, knowledgeable counseling, and care are almost nonexistent.
Here, we report on the availability, or lack thereof, of the abovementioned genetic services in Lebanon. We contacted the Ministry of Public Health (MOPH), private and public hospitals, and private medical laboratories. We also conducted a search on several governmental websites such as that for the Furthermore, individuals in high-risk communities, with increased prevalence of genetic diseases and high rates of consanguinity, endogamy, and arranged marriages, are in utmost need for genetic counseling. However, these communities are often in rural areas where genetic services do not exist. 3. Prevention and control. Patients suffering from genetically determined disorders have to deal with the burden of the increased frequency and length of hospital admissions and more surgeries (McCandless et al. 2004) , in addition to the high cost of ongoing management of genetic disorders. As reported by the WHO in 1996, prevention can help alleviate the significant cost of health care and the psychological burden not only on the affected individual and family but also on the society as a whole.
Genetic screening is at the core of any proper prevention program, yet it is very recent, primitive, and almost nonexistent in Lebanon. Genetic screening is testing individuals for the risk or the probability of developing a disease or the risk of having diseased offspring. Genetic diseases can be screened for at the level of the family with high risk for disease or the couple prior to marriage (carrier or premarital screening), the offspring prior to implantation (PGD), or prior to birth (prenatal screening), and the newborn (NBS). At each level, an intervention can be implemented to alleviate the burden of the expected outcome.
NBS is defined as the early detection of infants at increased risk for selected treatable diseases, mostly biochemical genetic diseases (inborn errors of metabolism (IEM)), through a nationally mandated public health program. The importance of NBS stems from the need for fast and early intervention in most of the identified IEMs, thus avoiding child mortality and in some instances morbidity. Screening for G6PDH deficiency, which is available at USJ, for example, decreases the chances of children having an anemic crisis in early childhood from 70 to below 10 % (Khneisser et al. 2007) .
AUBMC is one of the few hospitals with a hospital-based registry for congenital abnormalities that helped guide its NBS program testing for a few diseases. However, AUBMC sends samples from neonates of in-house deliveries to be tested at collaborating centers in Europe. The only two centers in Lebanon that offer on-site NBS for a few of these diseases are the Analytical Testing Laboratories (ATL), which is affiliated with the American University of Science and Technology (AUST), and the Newborn Screening Laboratory (NSL) at the Saint Joseph University (USJ). The NSL at USJ alone screens samples from 40 hospitals across Lebanon, for about 15,000 out of 74,000 newborns a year, and is now considered a reference laboratory for a well-established NBS program (Khneisser et al. 2008) . The abovementioned local laboratories are limited in technical expertise to tandem mass spectrometry (TMS), which is mostly used for screening purposes.
Due to the lack of a well-established comprehensive Biochemical Genetics Laboratory in Lebanon, cases that are positive on NBS or those that are suspected on a clinical basis to have an IEM are mostly confirmed by sending testing to certain European laboratories. This delays diagnosis by a significant amount of time and delays the timely initiation of treatment that is crucial in achieving satisfactory clinical outcomes in these cases.
The available NBS in Lebanon is, however, not mandatory, not publically funded, not re-reimbursed by health insurance plans, not available at any public institution, and not guided by a proper research assessment of the national incidence of IEMs. Most of the hospitals we contacted do not offer NBS, and those that outsource it do not inform the parents about the test unless there are unfavorable results. NBS should be implemented as a public health program, run by the public health system, and covering all steps in the prevention process: screening of all newborns for the most common and nationally relevant diseases, diagnostic confirmation of those newborns who screen positive (requires biochemical genetics laboratories, which are to date unavailable in Lebanon), referral for proper care (usually lifelong), and genetic counseling for the parents and family members.
As for the other aspects of a prevention program, although some are available, they are not being utilized in the context of a national prevention plan. The Lebanese government enforced premarital screening for several infectious diseases in 1994. However, among all the common genetic diseases, only thalassemia is screened for indirectly (measuring Hgb and MCV). This disease has also been ameliorated due to awareness campaign and the establishment of a tertiary care center for medical and emotional support (Inati et al. 2006) . Even if the couple chooses to undergo premarital genetic testing, there are no genetic counselors available to advise them toward an informed decision. Furthermore, carrier screening on the population level is not available as there has not been an assessment study for the most prevalent genetic diseases.
The technology for prenatal screening is also partially available in Lebanon ranging from ultrasound scanning accessible to almost everyone (detecting major congenital abnormalities such as neural tube defects and congenital heart malformations), to the less readily available assessment of maternal serum markers. Advanced prenatal diagnosis is even less available with invasive testing such as amniocentesis and chorionic villus sampling, available particularly at a few private hospitals at a relatively high cost. Despite availability, since selective termination of pregnancy is not legal and genetic counseling is absent, invasive procedures are not as effective in the prevention process. PGD, on the other hand, is more favorable as it allows the termination of the embryo prior to implantation and is available only at certain in vitro fertilization (IVF) centers in Lebanon. The costly and ethically challenging PGD along with IVF programs however is not under any public or governmental supervision or financial support.
Education in genetics
In addition to diagnostic services, sufficient clinical specialists, genetic counselors, and proper prevention plans, education in genetics is a major requirement in the proper implementation of community genetics services. There is a major deficit in genetic literacy at all levels including high-risk families, the general public, and even health care providers. Even institutions such as private hospitals and laboratories, when contacted directly and asked about the services which they claim to offer, could not properly define or differentiate between these genetic services (mostly laboratory testing). To the best of our knowledge, besides the hemoglobinopathy awareness campaigns conducted by the chronic care center, there are no other national awareness campaigns for the diagnosis, care, and prevention of genetic diseases.
Research in genetics
A quick look at the references (albeit not in a systematic manner) shows that most mechanistic analyses for genetic diseases are reported from the Lebanese Diaspora. Publications from Lebanon are mostly clinical, peer-reviewed reports with no dwelling on mechanisms or molecular analyses. Even for diseases that have only been reported in the Lebanese genome, mechanism studies are minimal. The lack of these studies prevents the international scientific community from obtaining valuable information about the function of many genes and pathways that may be beneficial in delineating other genetically transmitted conditions and diseases.
Concluding remarks
In light of the high number of genetic disorders in the Lebanese population and the lack of proper genetic services and knowledge, medical and research genetic societies in Lebanon have to play an urgent and important role in opening the dialogue with public health professionals and decision makers to initiate a process whereby Lebanon goes through a needs assessment and establishes preventive genetic programs and interventions with population health benefits. There is a need to nurture public health interest and participation in medical genetics. Currently, existing research data sets are not being used to increase public awareness and formulate intervention or strategic planning to decrease the burden in any manner. Efforts in that direction are minimal and personal.
Geographic and financial barriers to the utilization of available genetic services have to be addressed. The quality and availability of community genetics services, including counseling and screening programs, need to be enhanced. The MOPH has to initiate a national birth defect registry and launch a mandatory national NBS program accordingly. Introduction of counseling services has to follow a national dialogue to define ethical, legal, religious, and cultural factors that would guide interventions, such as those for prenatal genetic diagnosis and termination of the affected pregnancy. Carrier screening programs have to be evaluated in context of the prevalent genetic diseases. There is also a tremendous need to educate all sectors of the population about the role of genetics in health and disease, including related ethical, legal, and social issues perhaps through the introduction of scientifically based mass media campaigns and providing the public with a national source of information about genetic diseases, resources, and services. Finally, one could implement high impact action plans to increase awareness and training for primary health care providers including obstetricians and pediatricians to provide the necessary information and counseling to patients until proper strategies are drawn and put into action.
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